lanc Search Results


92
Proteintech lancl1
Clinical characteristics of PCa patients and <t> LanCL1 </t> expression
Lancl1, supplied by Proteintech, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lancl1/product/Proteintech
Average 92 stars, based on 1 article reviews
lancl1 - by Bioz Stars, 2026-03
92/100 stars
  Buy from Supplier

lanc  (Sony)
90
Sony lanc
Clinical characteristics of PCa patients and <t> LanCL1 </t> expression
Lanc, supplied by Sony, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lanc/product/Sony
Average 90 stars, based on 1 article reviews
lanc - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Sony rm-vd1 wired remote control
Clinical characteristics of PCa patients and <t> LanCL1 </t> expression
Rm Vd1 Wired Remote Control, supplied by Sony, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rm-vd1 wired remote control/product/Sony
Average 90 stars, based on 1 article reviews
rm-vd1 wired remote control - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
InterPro Inc lanc-like_protein_superfamily
Clinical characteristics of PCa patients and <t> LanCL1 </t> expression
Lanc Like Protein Superfamily, supplied by InterPro Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lanc-like_protein_superfamily/product/InterPro Inc
Average 90 stars, based on 1 article reviews
lanc-like_protein_superfamily - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Sony lanc interface
Clinical characteristics of PCa patients and <t> LanCL1 </t> expression
Lanc Interface, supplied by Sony, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lanc interface/product/Sony
Average 90 stars, based on 1 article reviews
lanc interface - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
InterPro Inc lanc-like
Clinical characteristics of PCa patients and <t> LanCL1 </t> expression
Lanc Like, supplied by InterPro Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lanc-like/product/InterPro Inc
Average 90 stars, based on 1 article reviews
lanc-like - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Medicago lanc-like protein gcl1
The miRNA-target gene pairs showed reverse expression patterns in the three comparison groups.
Lanc Like Protein Gcl1, supplied by Medicago, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lanc-like protein gcl1/product/Medicago
Average 90 stars, based on 1 article reviews
lanc-like protein gcl1 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Sony sony® lanc
The miRNA-target gene pairs showed reverse expression patterns in the three comparison groups.
Sony® Lanc, supplied by Sony, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sony® lanc/product/Sony
Average 90 stars, based on 1 article reviews
sony® lanc - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
InterPro Inc lanc enzymes
The miRNA-target gene pairs showed reverse expression patterns in the three comparison groups.
Lanc Enzymes, supplied by InterPro Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lanc enzymes/product/InterPro Inc
Average 90 stars, based on 1 article reviews
lanc enzymes - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
InterPro Inc lanc-like_prot_euk
The miRNA-target gene pairs showed reverse expression patterns in the three comparison groups.
Lanc Like Prot Euk, supplied by InterPro Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lanc-like_prot_euk/product/InterPro Inc
Average 90 stars, based on 1 article reviews
lanc-like_prot_euk - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Quelle GmbH chrest lanc 1479
The miRNA-target gene pairs showed reverse expression patterns in the three comparison groups.
Chrest Lanc 1479, supplied by Quelle GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/chrest lanc 1479/product/Quelle GmbH
Average 90 stars, based on 1 article reviews
chrest lanc 1479 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
LANCO Dr Lange GmbH Co KG lanc yellow flash thermometers high visibility
The miRNA-target gene pairs showed reverse expression patterns in the three comparison groups.
Lanc Yellow Flash Thermometers High Visibility, supplied by LANCO Dr Lange GmbH Co KG, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lanc yellow flash thermometers high visibility/product/LANCO Dr Lange GmbH Co KG
Average 90 stars, based on 1 article reviews
lanc yellow flash thermometers high visibility - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Clinical characteristics of PCa patients and  LanCL1  expression

Journal: Cell Death & Disease

Article Title: LanCL1 protects prostate cancer cells from oxidative stress via suppression of JNK pathway

doi: 10.1038/s41419-017-0207-0

Figure Lengend Snippet: Clinical characteristics of PCa patients and LanCL1 expression

Article Snippet: The primary antibody was LanCL1 (Proteintech, 1/600, 30 min).

Techniques: Expressing

a , b LanCL1 overexpression in LNCaP and PC-3 cells reduced cell death after 24 h treatment of 150 μM H2O2. Student’s t -test was performed for statistical significance analysis. N = 5. c , d LanCL1 knockdown increased LNCaP and PC-3 cells death induced by H 2 O 2 (100 μM H 2 O 2 , 24 h treatment). Student’s t -test was performed for statistical significance analysis. N = 5. e Hoechst staining shows that downregulation of LanCL1 increased LNCaP cell death(indicated by arrows) induced by H 2 O 2 , while LanCL1 overexpression reduced cell death. f Quantitation of the Hoechst staining of LNCaP cell treated by H 2 O 2 . Student’s t -test was performed for statistical significance analysis. N >3

Journal: Cell Death & Disease

Article Title: LanCL1 protects prostate cancer cells from oxidative stress via suppression of JNK pathway

doi: 10.1038/s41419-017-0207-0

Figure Lengend Snippet: a , b LanCL1 overexpression in LNCaP and PC-3 cells reduced cell death after 24 h treatment of 150 μM H2O2. Student’s t -test was performed for statistical significance analysis. N = 5. c , d LanCL1 knockdown increased LNCaP and PC-3 cells death induced by H 2 O 2 (100 μM H 2 O 2 , 24 h treatment). Student’s t -test was performed for statistical significance analysis. N = 5. e Hoechst staining shows that downregulation of LanCL1 increased LNCaP cell death(indicated by arrows) induced by H 2 O 2 , while LanCL1 overexpression reduced cell death. f Quantitation of the Hoechst staining of LNCaP cell treated by H 2 O 2 . Student’s t -test was performed for statistical significance analysis. N >3

Article Snippet: The primary antibody was LanCL1 (Proteintech, 1/600, 30 min).

Techniques: Over Expression, Knockdown, Staining, Quantitation Assay

a Data from The Human Protein Atlas portal show LanCL1 expression in different tissues. Prostate is indicated by red arrow. b IHC data from The Human Protein Atlas portal show LanCL1 expression is higher in prostate cancer tissues than in normal tissues. c . Western blotting was used to detect the LanCL1 expression in human prostate cell lines. Tubulin served as the control. d Quantitation of relative expression of LanCL1 protein in different prostate cancer cell lines. e , f Increased expression markedly correlates with high Gleason score and tumor stage, data from the TCGA data set (queried from cBioPortal). LanCL1 expression is exon-normalized signal intensity. Mann–Whitney U -tests were performed to assess statistical significance for the comparisons between groups

Journal: Cell Death & Disease

Article Title: LanCL1 protects prostate cancer cells from oxidative stress via suppression of JNK pathway

doi: 10.1038/s41419-017-0207-0

Figure Lengend Snippet: a Data from The Human Protein Atlas portal show LanCL1 expression in different tissues. Prostate is indicated by red arrow. b IHC data from The Human Protein Atlas portal show LanCL1 expression is higher in prostate cancer tissues than in normal tissues. c . Western blotting was used to detect the LanCL1 expression in human prostate cell lines. Tubulin served as the control. d Quantitation of relative expression of LanCL1 protein in different prostate cancer cell lines. e , f Increased expression markedly correlates with high Gleason score and tumor stage, data from the TCGA data set (queried from cBioPortal). LanCL1 expression is exon-normalized signal intensity. Mann–Whitney U -tests were performed to assess statistical significance for the comparisons between groups

Article Snippet: The primary antibody was LanCL1 (Proteintech, 1/600, 30 min).

Techniques: Expressing, Western Blot, Control, Quantitation Assay, MANN-WHITNEY

a Representative immunohistochemistry of LanCL1 on benign prostatic epithelia (benign) and prostate cancer tissues (Gleason score 6 or 9). Student’s t-test was performed for statistical significance analysis. b Quantitation of protein expression of LanCL1 in benign or prostate cancer tissues. c Western blot analysis of LanCL1 expression in 15 pairs of nontumor tissues (P) and PCa tissues (T). Student’s t-test was performed for statistical significance analysis. N = 15. d Immunohistochemical staining for LanCL1 protein in the dorsolateral prostate of WT and TRAMP mice

Journal: Cell Death & Disease

Article Title: LanCL1 protects prostate cancer cells from oxidative stress via suppression of JNK pathway

doi: 10.1038/s41419-017-0207-0

Figure Lengend Snippet: a Representative immunohistochemistry of LanCL1 on benign prostatic epithelia (benign) and prostate cancer tissues (Gleason score 6 or 9). Student’s t-test was performed for statistical significance analysis. b Quantitation of protein expression of LanCL1 in benign or prostate cancer tissues. c Western blot analysis of LanCL1 expression in 15 pairs of nontumor tissues (P) and PCa tissues (T). Student’s t-test was performed for statistical significance analysis. N = 15. d Immunohistochemical staining for LanCL1 protein in the dorsolateral prostate of WT and TRAMP mice

Article Snippet: The primary antibody was LanCL1 (Proteintech, 1/600, 30 min).

Techniques: Immunohistochemistry, Quantitation Assay, Expressing, Western Blot, Immunohistochemical staining, Staining

a Stably transfected LNCaP cells and PC-3 cells interfered with LanCL1 were established. LanCL1 was knockdown by siRNA as indicated. The efficiency of knockdown were examined by western blotting. Tubulin served as the control. b Cell proliferation was measured at the indicated time points by MTS colorimetric assay (absorbance at 490 nm (OD490). Student’s t -test was performed for statistical significance analysis. N >3. * P <0.05, ** P <0.01, *** P <0.001 c Tumor growth in LanCL1 overexpressed PC-3 cells and control cells was investigated by xenograft tumor models. Student’s t-test was performed for statistical significance analysis. N = 7. ** P <0.01, *** P <0.001. d The cell cycle distribution was analyzed by fluorescent-activated cell scanning (FACS) in LanCL1 overexpressed LNCaP cells. e Column chart indicates the mean and SEM of the S-phase fraction for each cell. Student’s t-test was performed for statistical significance analysis. N = 5

Journal: Cell Death & Disease

Article Title: LanCL1 protects prostate cancer cells from oxidative stress via suppression of JNK pathway

doi: 10.1038/s41419-017-0207-0

Figure Lengend Snippet: a Stably transfected LNCaP cells and PC-3 cells interfered with LanCL1 were established. LanCL1 was knockdown by siRNA as indicated. The efficiency of knockdown were examined by western blotting. Tubulin served as the control. b Cell proliferation was measured at the indicated time points by MTS colorimetric assay (absorbance at 490 nm (OD490). Student’s t -test was performed for statistical significance analysis. N >3. * P <0.05, ** P <0.01, *** P <0.001 c Tumor growth in LanCL1 overexpressed PC-3 cells and control cells was investigated by xenograft tumor models. Student’s t-test was performed for statistical significance analysis. N = 7. ** P <0.01, *** P <0.001. d The cell cycle distribution was analyzed by fluorescent-activated cell scanning (FACS) in LanCL1 overexpressed LNCaP cells. e Column chart indicates the mean and SEM of the S-phase fraction for each cell. Student’s t-test was performed for statistical significance analysis. N = 5

Article Snippet: The primary antibody was LanCL1 (Proteintech, 1/600, 30 min).

Techniques: Stable Transfection, Transfection, Knockdown, Western Blot, Control, Colorimetric Assay

a qRT–PCR shows no induction of LanCL1 mRNA in H 2 O 2 -treated (100 μM, 1 h) LNCaP cells. Student’s t -test was performed for statistical significance analysis. N = 3. b , c Western blots and quantification show that H 2 O 2 -treatment did not induce LanCL1 protein expression. Student’s t-test was performed for statistical significance analysis. N = 5. d – f Western blots and quantification show an increase in the level of 4-HNE in the H 2 O 2 -treated (100 μM, 1 h) LNCaP cells, but LanCL1 overexpression did not influence the level of 4-HNE. Western blots show that LanCL1 overexpression in LNCaP cells is not more resistant to H 2 O 2 -induced 4-HNE accumulation. Student’s t-test was performed for statistical significance analysis. N = 5. g ROS determination by using a fluorescent probe DCFH-DA in LNCaP and PC-3 cells untreated and treated with H 2 O 2 (100 μM, 1 h). Student’s t-test was performed for statistical significance analysis. N = 3

Journal: Cell Death & Disease

Article Title: LanCL1 protects prostate cancer cells from oxidative stress via suppression of JNK pathway

doi: 10.1038/s41419-017-0207-0

Figure Lengend Snippet: a qRT–PCR shows no induction of LanCL1 mRNA in H 2 O 2 -treated (100 μM, 1 h) LNCaP cells. Student’s t -test was performed for statistical significance analysis. N = 3. b , c Western blots and quantification show that H 2 O 2 -treatment did not induce LanCL1 protein expression. Student’s t-test was performed for statistical significance analysis. N = 5. d – f Western blots and quantification show an increase in the level of 4-HNE in the H 2 O 2 -treated (100 μM, 1 h) LNCaP cells, but LanCL1 overexpression did not influence the level of 4-HNE. Western blots show that LanCL1 overexpression in LNCaP cells is not more resistant to H 2 O 2 -induced 4-HNE accumulation. Student’s t-test was performed for statistical significance analysis. N = 5. g ROS determination by using a fluorescent probe DCFH-DA in LNCaP and PC-3 cells untreated and treated with H 2 O 2 (100 μM, 1 h). Student’s t-test was performed for statistical significance analysis. N = 3

Article Snippet: The primary antibody was LanCL1 (Proteintech, 1/600, 30 min).

Techniques: Quantitative RT-PCR, Western Blot, Expressing, Over Expression

a , b Modulation of apoptosis related signaling proteins using antibody array assay. Total protein was extracted from LNCaP-NEO and LNCaP-LanCL1 cells. A slide-based antibody array was used for simultaneous detection of 19 signaling molecules involved in stress response and apoptosis using a PathScan Stress and Apoptosis Signaling Array kit. Each protein was arranged in duplicate. c The proteins with changes concentration included pP44/42 MAPK (ERK1/2) (Thr202/Try204), pAkt(S473), pHSP27(Ser82), pSmad2(Ser465), pP53(Ser15), pP38 MAPK(Thr180/Try182), pSAPK/JNK(Thr183/Try185) and Cleaved-Caspase-3(Asp175), which were indicated on the images, and quantified. d The concentrations of the protein in c were quantified. Student’s t -test was performed for statistical significance analysis. N = 3. Data are presented as mean ± SEM. * P <0.05, ** P <0.01, *** P <0.001. e Luciferase assay shows that overexpression of LanCL1 reduced AP-1 transcription. Student’s t-test was performed for statistical significance analysis. N = 3. *** P <0.001 f Western blotting indicated the protein level of pSAPK/JNK(Thr183/Try185) in overexpression LNCaP and PC-3 cells. Student’s t -test was performed for statistical significance analysis. N = 3. g Western blotting indicated the protein level of pSAPK/JNK(Thr183/Try185) in overexpression LNCaP cells after 100 μM H 2 O 2 for 2 h. Student’s t-test was performed for statistical significance analysis. N = 3. H. SP600125 partially rescued the cell death caused by ROS in LanCL1 knockdown LNCaP cells. Student’s t-test was performed for statistical significance analysis. N = 5

Journal: Cell Death & Disease

Article Title: LanCL1 protects prostate cancer cells from oxidative stress via suppression of JNK pathway

doi: 10.1038/s41419-017-0207-0

Figure Lengend Snippet: a , b Modulation of apoptosis related signaling proteins using antibody array assay. Total protein was extracted from LNCaP-NEO and LNCaP-LanCL1 cells. A slide-based antibody array was used for simultaneous detection of 19 signaling molecules involved in stress response and apoptosis using a PathScan Stress and Apoptosis Signaling Array kit. Each protein was arranged in duplicate. c The proteins with changes concentration included pP44/42 MAPK (ERK1/2) (Thr202/Try204), pAkt(S473), pHSP27(Ser82), pSmad2(Ser465), pP53(Ser15), pP38 MAPK(Thr180/Try182), pSAPK/JNK(Thr183/Try185) and Cleaved-Caspase-3(Asp175), which were indicated on the images, and quantified. d The concentrations of the protein in c were quantified. Student’s t -test was performed for statistical significance analysis. N = 3. Data are presented as mean ± SEM. * P <0.05, ** P <0.01, *** P <0.001. e Luciferase assay shows that overexpression of LanCL1 reduced AP-1 transcription. Student’s t-test was performed for statistical significance analysis. N = 3. *** P <0.001 f Western blotting indicated the protein level of pSAPK/JNK(Thr183/Try185) in overexpression LNCaP and PC-3 cells. Student’s t -test was performed for statistical significance analysis. N = 3. g Western blotting indicated the protein level of pSAPK/JNK(Thr183/Try185) in overexpression LNCaP cells after 100 μM H 2 O 2 for 2 h. Student’s t-test was performed for statistical significance analysis. N = 3. H. SP600125 partially rescued the cell death caused by ROS in LanCL1 knockdown LNCaP cells. Student’s t-test was performed for statistical significance analysis. N = 5

Article Snippet: The primary antibody was LanCL1 (Proteintech, 1/600, 30 min).

Techniques: Ab Array, Concentration Assay, Luciferase, Over Expression, Western Blot, Knockdown

The miRNA-target gene pairs showed reverse expression patterns in the three comparison groups.

Journal: Frontiers in Plant Science

Article Title: Utilization of Transcriptome, Small RNA, and Degradome Sequencing to Provide Insights Into Drought Stress and Rewatering Treatment in Medicago ruthenica

doi: 10.3389/fpls.2021.675903

Figure Lengend Snippet: The miRNA-target gene pairs showed reverse expression patterns in the three comparison groups.

Article Snippet: , mtr-MIR2603-p3_2ss9AC17AC , ↑ , TRINITY_DN22815_c0_g1 , ↓ , lanC-like protein GCL1 ( Medicago truncatula ).

Techniques: Expressing, Comparison, Ubiquitin Proteomics, Sequencing